
Virpax Pharmaceuticals, Inc.
$40 M
Follow-On Offering
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Advisor
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Capital Markets Advisor
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Sole Placement Agent
Sole Book-Runner